Pepstatin A alters host cell autophagic machinery and leads to a decrease in influenza A virus production

Autophagy is a survival mechanism that can take place in cells under metabolic stress and through which cells can recycle waste material. Disturbances in autophagic processes appear to be associated with a number of human pathologies, including viral infections. It has been hypothesized that viruses...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 226; no. 12; pp. 3368 - 3377
Main Authors Matarrese, Paola, Nencioni, Lucia, Checconi, Paola, Ciarlo, Laura, Gambardella, Lucrezia, Ascione, Barbara, Sgarbanti, Rossella, Garaci, Enrico, Malorni, Walter, Palamara, Anna Teresa
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.12.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Autophagy is a survival mechanism that can take place in cells under metabolic stress and through which cells can recycle waste material. Disturbances in autophagic processes appear to be associated with a number of human pathologies, including viral infections. It has been hypothesized that viruses can subvert autophagy in order to penetrate the host cell and replicate. Because it has been suggested that autophagy is involved in influenza A virus replication, we analyzed the effects of two inhibitors of lysosomal proteases on the cellular control of influenza A virus replication. In particular, we used biochemical and morphological analyses to evaluate the modulation of influenza A/Puerto Rico/8/34 H1N1 virus production in the presence of CA074 and Pepstatin A, inhibitors of cathepsin proteases B and D, respectively. We found that Pepstatin A, but not CA074, significantly hindered influenza virus replication, probably by modulating host cell autophagic/apoptotic responses. These results are of potential interest to provide useful insights into the molecular pathways exploited by the influenza in order to replicate and to identify further cellular factors as targets for the development of innovative antiviral strategies. J. Cell. Physiol. 226: 3368–3377, 2011. © 2011 Wiley Periodicals, Inc.
Bibliography:The Italian Ministry of Health - No. Studio e sviluppo di nuovi farmaci antivirali contro infezioni da A-H1N1
ark:/67375/WNG-N6M0DRST-R
Ateneo and Fondazione Roma
ArticleID:JCP22696
The Italian Ministry of Education, University, and Research - No. FIRB RBIP067F9E and Reti FIRB RBPR05NWWC_006
istex:0EF8475C8FFE6B47EA786AF2018AB7AF3D9A7F8E
Paola Matarrese and Lucia Nencioni to be considered as first authors.
Walter Malorni and Anna Teresa Palamara to be considered as senior investigators.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9541
1097-4652
DOI:10.1002/jcp.22696